Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
David Hooper, MD |
VIRTUUS Children’s Study-Validating Injury to the Renal Transplant Using Urinary Signatures in Children |
Children's Hospital of Philadelphia (National Institutes of Health) |
3200880522 |
06/01/2019 - 05/31/2020 |
$11,736 |
David Hooper, MD |
Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant |
University of Minnesota (Department of Defense) |
N006814103 |
09/01/2019 - 08/31/2020 |
$30,000 |
David Hooper, MD |
Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant |
University of Minnesota (Department of Defense) |
N006814103 |
09/01/2019 - 08/31/2022 |
$90,000 |
Mark M Mitsnefes, MD |
CKID IV (patient care only).SPR200909 = cost reimbursable portion of this project. |
Children's Mercy Hospital (National Institutes of Health) |
18-0007 |
08/01/2019 - 07/31/2020 |
$18,972 |
Mark M Mitsnefes, MD |
CKID IV (patient care and salaries)SPR200839 = patient care portion of this project |
Children's Mercy Hospital (National Institutes of Health) |
18-0007 |
08/01/2019 - 07/31/2020 |
$64,853 |
Prasad Devarajan, MD |
ISN - SRC Grant 2020 |
International Society of Nephrology |
SRC India-USA7_Devar |
01/01/2020 - 12/31/2020 |
$12,000 |
Prasad Devarajan, MD |
Critical Translational Studies in Pediatric Nephrology |
National Institutes of Health (NIH) |
P50 DK096418 |
09/01/2019 - 08/31/2020 |
$877,890 |
Prasad Devarajan, MD |
Research Training in Pediatric Nephrology |
National Institutes of Health (NIH) |
T32DK007695 |
07/01/2019 - 06/30/2020 |
$155,686 |
Prasad Devarajan, MD
Katherine E Yutzey, PHD |
Targeting pathologic G-protein signaling in cardiac and kidney fibrosis |
National Institutes of Health (NIH) |
R01HL133695 |
08/01/2019 - 07/31/2020 |
$222,172 |
Stuart Goldstein, MD |
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POPS) |
Duke University (National Institutes of Health) |
HHSN-275201800003I T |
04/08/2020 - 04/07/2021 |
$87,248 |
Stuart Goldstein, MD |
Urinary NGAL Levels and Furosemide Responsiveness in Neonatal AKI |
Little Giraffe Foundation |
Little Giraffe Fndtn |
09/16/2019 - 09/16/2020 |
$5,000 |
Current Year Direct |
$1,575,557 |